PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: RedLine Public Relations

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Astell Wins the Space Race - Double Your Autoclave Capacity without Increasing the Footprint - Astell, autoclave and steriliser manufacturer, launch new Duaclave range
Astell Wins the Space Race - Double Your Autoclave Capacity without Increasing the Footprint

 

NewswireToday - /newswire/ - Princes Risborough, Bucks, United Kingdom, 2010/02/22 - Astell, autoclave and steriliser manufacturer, launch new Duaclave range.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Astell, the leading autoclave and steriliser manufacturers, have solved the eternal problem of how to double your laboratory’s autoclave capacity without increasing the equipment footprint. Their new Duaclave range combines two identical chambers, one directly above the other within one frame.

The two chambers come equipped with all the features that Astell users have come to expect like delayed start, allowing sterilisation to take place overnight, Holdwarm capability to maintain the autoclave at a pre-set temperature after sterilisation until required and data archiving to ensure that all cycle details are automatically recorded and saved.

The two chambers are fully independent and each has its own Logi control system accessed via a full colour, icon-driven touch screen with password protected security. This means that, for example, while one chamber may be processing fluids, the other can either be sitting idle or perhaps completing a discard load.

The range includes both electrically heated and direct steam heated models, and options include load sensed process timing, assisted cooling and assisted cooling.

As with all Astell autoclaves and sterilisers, the Duaclave range is CE marked and manufactured to comply with the Pressure Equipment Directive PD97/23/EC, the Medical Devices Directive MDD 93/42/EEC and all other applicable UK and international standards. Full IQ and OQ documentation is available for all models.

Astell Duaclave autoclaves are available in 33, 43, 63, 120 and 153 litre chamber sizes to suit most laboratory applications including sterilisation of reagents and media, glassware, laboratory instruments and discard.

Contact Astell (astell.com) for further information on sterilisation solutions.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: RedLine Public Relations

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Astell Wins the Space Race - Double Your Autoclave Capacity without Increasing the Footprint

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Astell.com |
Publisher Contact: Jane Wardrop - Redline-PR.co.uk 
+44(0)18 4427 3407 sales[.]astell.com www.astell.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any RedLine Public Relations securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From RedLine Public Relations / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Triggr & Bloom





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)